Given OGT’s role in maintaining hematopoietic stem cells by ensuring mitochondrial quality [34], we proposed that OGT loss-induced changes in O-GlcNAc modification could underlie the metabolic alterations associated with TRAF6 loss in AML. The gene discussed is TRAF6; the disease is acute myeloid leukemia.